Trials / Completed
CompletedNCT00090298
Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)
A Multicenter, Randomized, Double-Blind Study to Evaluate the Lipid-Altering Efficacy and Safety of the Ezetimibe/Simvastatin Combination Tablet Versus Rosuvastatin in Patients With Primary Hypercholesterolemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2,815 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
A 10-week study to compare the reduction in cholesterol following treatment with two different marketed drugs in patients with hypercholesterolemia.
Detailed description
The duration of treatment is 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0653A, ezetimibe (+) simvastatin | |
| DRUG | Comparator: Rosuvastatin |
Timeline
- Start date
- 2004-04-01
- Primary completion
- 2004-12-01
- Completion
- 2004-12-01
- First posted
- 2004-08-30
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00090298. Inclusion in this directory is not an endorsement.